Publicação

Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells

Ver documento

Detalhes bibliográficos
Resumo:Given the growing interest in deep eutectic systems (DES) for their remarkable physicochemical and biological properties, and their alignment with green chemistry principles, we explored their therapeutic potential against colorectal cancer (CRC) in this study. The reported promising selective toxicity of therapeutic deep eutectic systems (THEDES), combining a terpene (menthol, thymol, perillyl alcohol and limonene) with ibuprofen (Ibu), towards CRC cells, have pushed them forward as potential alternative or complementary therapeutics towards CRC. These systems are considered THEDES since they are eutectic systems with a pharmaceutic ingredient as part of its composition. To leverage THEDES viability as CRC therapeutics, different drug delivery systems (DDS), based on poly (lactic-co-glycolic acid) nanoparticles (PLGA-NPs), liposomes (LPS) or niosomes, were explored to ensure THEDES accumulation in cancer sites. For that, nanoprecipitation, microfluidics and thin-film hydration methods were used, respectively, to produce THEDES encapsulated DDS. From the different DDS produced, LPS presented the most promising results regarding size (200 nm), monodispersity, and negative zeta potential averaging −30 mV. These results indicate LPS as a stable, monodispersed particle suspension suitable for cancer-related applications, hence, these NPs were selected for further assessments. The obtained THEDES-LPS revealed expected morphology upon electron microscopy observation (TEM), a 10 % release after 96h, and a maximum encapsulation efficiency (EE%) of 41 % obtained for limonene (Lim):Ibu (4:1). All THEDES-LPS revealed antiproliferative activity towards HT-29 cells which envisage LPS as a DDS for THEDES towards CRC.
Autores principais:Oliveira, Filipe
Outros Autores:Pereira, Joana; Neca, Carolina; Mansor, Muhamad Hawari; Gao, Zijian; Muthana, Munitta; Duarte, Ana Rita C.
Assunto:Colorectal cancer Drug delivery systems Liposomes Nanoparticles Niosomes Polymeric nanoparticles Therapeutic deep eutectic systems Pharmaceutical Science SDG 3 - Good Health and Well-being
Ano:2025
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1868415488103546880
author Oliveira, Filipe
author2 Pereira, Joana
Neca, Carolina
Mansor, Muhamad Hawari
Gao, Zijian
Muthana, Munitta
Duarte, Ana Rita C.
author2_role author
author
author
author
author
author
author_facet Oliveira, Filipe
Pereira, Joana
Neca, Carolina
Mansor, Muhamad Hawari
Gao, Zijian
Muthana, Munitta
Duarte, Ana Rita C.
author_role author
contributor_name_str_mv DQ - Departamento de Química
LAQV@REQUIMTE
Editions de Sante
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Oliveira, Filipe\"},{\"Person.name\":\"Pereira, Joana\"},{\"Person.name\":\"Neca, Carolina\"},{\"Person.name\":\"Mansor, Muhamad Hawari\"},{\"Person.name\":\"Gao, Zijian\"},{\"Person.name\":\"Muthana, Munitta\"},{\"Person.name\":\"Duarte, Ana Rita C.\"}]
datacite.contributors.contributor.contributorName.fl_str_mv DQ - Departamento de Química
LAQV@REQUIMTE
Editions de Sante
RUN
datacite.creators.creator.creatorName.fl_str_mv Oliveira, Filipe
Pereira, Joana
Neca, Carolina
Mansor, Muhamad Hawari
Gao, Zijian
Muthana, Munitta
Duarte, Ana Rita C.
datacite.date.Accepted.fl_str_mv 2025-12-01T00:00:00Z
datacite.date.available.fl_str_mv 2026-02-12T12:07:01Z
datacite.date.embargoed.fl_str_mv 2026-02-12T12:07:01Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
dc.contributor.none.fl_str_mv DQ - Departamento de Química
LAQV@REQUIMTE
Editions de Sante
RUN
dc.creator.none.fl_str_mv Oliveira, Filipe
Pereira, Joana
Neca, Carolina
Mansor, Muhamad Hawari
Gao, Zijian
Muthana, Munitta
Duarte, Ana Rita C.
dc.date.Accepted.fl_str_mv 2025-12-01T00:00:00Z
dc.date.available.fl_str_mv 2026-02-12T12:07:01Z
dc.date.embargoed.fl_str_mv 2026-02-12T12:07:01Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/200325
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Given the growing interest in deep eutectic systems (DES) for their remarkable physicochemical and biological properties, and their alignment with green chemistry principles, we explored their therapeutic potential against colorectal cancer (CRC) in this study. The reported promising selective toxicity of therapeutic deep eutectic systems (THEDES), combining a terpene (menthol, thymol, perillyl alcohol and limonene) with ibuprofen (Ibu), towards CRC cells, have pushed them forward as potential alternative or complementary therapeutics towards CRC. These systems are considered THEDES since they are eutectic systems with a pharmaceutic ingredient as part of its composition. To leverage THEDES viability as CRC therapeutics, different drug delivery systems (DDS), based on poly (lactic-co-glycolic acid) nanoparticles (PLGA-NPs), liposomes (LPS) or niosomes, were explored to ensure THEDES accumulation in cancer sites. For that, nanoprecipitation, microfluidics and thin-film hydration methods were used, respectively, to produce THEDES encapsulated DDS. From the different DDS produced, LPS presented the most promising results regarding size (200 nm), monodispersity, and negative zeta potential averaging −30 mV. These results indicate LPS as a stable, monodispersed particle suspension suitable for cancer-related applications, hence, these NPs were selected for further assessments. The obtained THEDES-LPS revealed expected morphology upon electron microscopy observation (TEM), a 10 % release after 96h, and a maximum encapsulation efficiency (EE%) of 41 % obtained for limonene (Lim):Ibu (4:1). All THEDES-LPS revealed antiproliferative activity towards HT-29 cells which envisage LPS as a DDS for THEDES towards CRC.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/19c0d92b-0055-4284-a051-5d01695ff8ae/download
id run_320e17e050fa6042902c4aebbd737c71
identifier.url.fl_str_mv http://hdl.handle.net/10362/200325
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/200325
organization_str_mv urn:organizationAcronym:unl
person_str_mv Oliveira, Filipe
Pereira, Joana
Neca, Carolina
Mansor, Muhamad Hawari
Gao, Zijian
Muthana, Munitta
Duarte, Ana Rita C.
publishDate 2025
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenGiven the growing interest in deep eutectic systems (DES) for their remarkable physicochemical and biological properties, and their alignment with green chemistry principles, we explored their therapeutic potential against colorectal cancer (CRC) in this study. The reported promising selective toxicity of therapeutic deep eutectic systems (THEDES), combining a terpene (menthol, thymol, perillyl alcohol and limonene) with ibuprofen (Ibu), towards CRC cells, have pushed them forward as potential alternative or complementary therapeutics towards CRC. These systems are considered THEDES since they are eutectic systems with a pharmaceutic ingredient as part of its composition. To leverage THEDES viability as CRC therapeutics, different drug delivery systems (DDS), based on poly (lactic-co-glycolic acid) nanoparticles (PLGA-NPs), liposomes (LPS) or niosomes, were explored to ensure THEDES accumulation in cancer sites. For that, nanoprecipitation, microfluidics and thin-film hydration methods were used, respectively, to produce THEDES encapsulated DDS. From the different DDS produced, LPS presented the most promising results regarding size (200 nm), monodispersity, and negative zeta potential averaging −30 mV. These results indicate LPS as a stable, monodispersed particle suspension suitable for cancer-related applications, hence, these NPs were selected for further assessments. The obtained THEDES-LPS revealed expected morphology upon electron microscopy observation (TEM), a 10 % release after 96h, and a maximum encapsulation efficiency (EE%) of 41 % obtained for limonene (Lim):Ibu (4:1). All THEDES-LPS revealed antiproliferative activity towards HT-29 cells which envisage LPS as a DDS for THEDES towards CRC.application/pdfenNanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cellsOliveira, FilipePereira, JoanaNeca, CarolinaMansor, Muhamad HawariGao, ZijianMuthana, MunittaDuarte, Ana Rita C.DQ - Departamento de QuímicaLAQV@REQUIMTEEditions de SanteHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf1773-2247URNIsPartOfPURE: 152910442URNIsPartOfPURE UUID: da56cc69-6d37-4860-a714-e04db2220599URNIsPartOfScopus: 105025707948URNIsPartOfWOS: 001583833000003URNIsPartOfORCID: /0000-0003-0800-0112/work/205572061DOIIsPartOf10.1016/j.jddst.2025.1075172026-02-12T12:07:01Z2025-122025-12-01T00:00:00ZHandlehttp://hdl.handle.net/10362/200325http://purl.org/coar/access_right/c_abf2open accessColorectal cancerDrug delivery systemsLiposomesNanoparticlesNiosomesPolymeric nanoparticlesTherapeutic deep eutectic systemsPharmaceutical ScienceSDG 3 - Good Health and Well-being63875 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/19c0d92b-0055-4284-a051-5d01695ff8ae/download
spellingShingle Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
Oliveira, Filipe
Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
status SINGLETON
subject.fl_str_mv Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
title Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
title_full Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
title_fullStr Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
title_full_unstemmed Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
title_short Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
title_sort Nanoparticle platforms for encapsulation of therapeutic deep eutectic systems to target colorectal cancer cells
topic Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
topic_facet Colorectal cancer
Drug delivery systems
Liposomes
Nanoparticles
Niosomes
Polymeric nanoparticles
Therapeutic deep eutectic systems
Pharmaceutical Science
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/200325
visible 1